Ghana Hosts Fill-and-Finish Plant for BioNTech's COVID-19 Vaccine

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Ghana is set to host a fill-and-finish facility for German biotechnology manufacturing major BioNTech SE's (NASDAQ:BNTX) (Germany) COVID-19 vaccine.

German process engineering major Glatt Ingenieurtechnik GmbH (Glatt) (Weimar, Germany) has been commissioned to conduct a concept study to investigate the technical and economic aspects of the proposed plant, which will be operated by DEK Vaccines Limited, a consortium of three local pharmaceutical manufacturers.

The plant initially will be set up for filling and finishing the COVID vaccine, but eventually will package other human vaccines as well. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for related project reports.

Industrial Info is tracking 143 capital projects worth US$3.2 billion in Africa's Pharmaceutical and Biotech Industry. Subscribers to the GMI database can click here for a list.

Industrial Info Resources (IIR) is the world's leading provider of market intelligence across the upstream, midstream and downstream energy markets and all other major industrial markets. IIR's Global Market Intelligence Platform (GMI) supports our end-users across their core businesses, and helps them connect trends across multiple markets with access to real, qualified and validated project opportunities. Follow IIR on: LinkedIn.